Keywords: Abraxane, Breast cancer, New Zealand, Specialised Therapeutics, Celgene

Breast cancer drug Abraxane now available in New Zealand

Article | 22 February 2011

Print This

Following approval from the local regulatory authority, women in New Zealand now have access to the breast cancer drug Abraxane ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in